The contract research organization consolidation trend continues with Worldwide Clinical Trials striking a deal for Catalyst Clinical Research, which has particular expertise in oncology. Worldwide is a portfolio company of Kohlberg, a private equity firm. The post Worldwide Clinical Trials to Buy Catalyst, Another M&A Deal Between Private Equity-Backed CROs appeared first on MedCity News.
As OpenAI and Anthropic move deeper into healthcare, experts say AI chatbots are becoming the new front door to medicine. This shift is shaking things up for some health tech startups, redefining the patient-provider relationship, and intensifying debates over safety, privacy and accountability. The post What Does OpenAI and Anthropic’s Healthcare Push Means for the…
AnswersNow’s Series B round was led by HealthQuest Capital, with participation from Left Lane Capital and Owl Ventures. The post AnswersNow Raises $40M to Expand Access to Autism Therapy appeared first on MedCity News.
I lived for nine years with ALS while navigating a healthcare system that routinely obscured my own medical reality. But I know that pain is only amplified for individuals without medical expertise like mine. The post We Have a Problem: Even Doctors Struggle to Navigate our Healthcare System appeared first on MedCity News.
When MRD testing evolves from a numerical readout into a definition of clonal behavior, it becomes what clinicians have needed all along: a tool that informs action, not just detection. The post Same Mutation, Different Fate appeared first on MedCity News.
About 31,000 Kaiser Permanente healthcare workers plan to launch an open-ended strike over staffing shortages, wages and care access issues — potentially affecting dozens of hospitals and hundreds of clinics in California and Hawaii. While Kaiser blames unions for stalled negotiations, workers say the conflict reflects deeper concerns about patient safety, burnout and health systems’…
Alkermes is chasing Takeda Pharmaceutical, whose orexin receptor-targeting pill is on track to become first in a new class of narcolepsy medicines. Blair Jackson, chief operating officer of the neuroscience biotech, says Alkermes’s drug offers advantages and also paves the way to bring orexin agonism to other indications. The post Neuroscience Biotech Alkermes Sees Narcolepsy…
Zarminali’s Series A round was led by Healthier Capital and included participation from General Catalyst and K2 HealthVentures. The post Zarminali Pediatrics Lands $110M to Reshape Pediatric Care appeared first on MedCity News.
By adopting a modern digital payment solution, payers can streamline operations, improve provider relationships and reduce fraud exposure. Most importantly, they gain a flexible, scalable foundation built to meet today’s demands and tomorrow’s challenges. The post Healthcare’s Paper Check Problem appeared first on MedCity News.
[Sponsored] For health care leaders and innovators, direct-access physical therapy presents an opportunity. The post Top-Rated Direct-Access Physical Therapy Clinics in Chicago appeared first on MedCity News.